Skip to main content
All lobbying filings

AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION

Lobbying for AMERICAN ACADEMY OF DERMATOLOGY ASSOCIATION

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 19, 2026
Expenses
$2,047,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Lobbying activity 5

H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025

H.R. 3686, the SAFE Sunscreen Standards Act; H.R. 4273/S. 2292, Over-the-Counter Monograph Drug User Fee Amendments; H.R. 5509/S. 2903, the Safe Step Act; H.R. 4002, the Patient Access to Higher Quality Health Care Act of 2025 Clinical Laboratory Improvement Amendment

H.R. 1940, the Tanning Tax Repeal Act of 2025; H.R. 1, the One Big Beautiful Bill Act

Revised military shaving waiver policies; Sunscreen access for servicemembers

H.R. 879/S. 1640, the Medicare Patient Access and Practice Stabilization Act of 2025; H.R. 1, the One Big Beautiful Bill Act; H.R. 3164/S. 2426, the Ensuring Community Access to Pharmacist Services Act; Draft legislation to amend title XVIII of the Social Security Act to modify the conversion factor updates applicable to physicians' services under the Medicare program; Implementation of Centers for Medicare & Medicaid Services. (2025). Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program. Federal Register, 88, 90 FR 49266-50481; H.R. 6160, the Strengthening Medicare for Patients and Providers Act; H.R. 8163, the Provider Reimbursement Stability Act; H.R. 7520, the Efficiency Adjustment Delay Act; H.R. 8622, the Medicare Physician Data-driven Performance Payment System Act of 2026 H.R.9693, Patients First Act of 2026 H.R.4331, Access to Claims Data Act Proposed CY 2027 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program

 Bills named in this filing 19
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
  • H.R. 3686
    SAFE Sunscreen Standards Act
  • H.R. 4273
    Over-the-Counter Monograph Drug User Fee Amendments
  • S. 2292
    Over-the-Counter Monograph Drug User Fee Amendments
  • H.R. 5509
    Safe Step Act
  • S. 2903
    Safe Step Act
  • H.R. 4002
    Patient Access to Higher Quality Health Care Act of 2025
  • H.R. 1940
    Tanning Tax Repeal Act of 2025
  • H.R. 1
    One Big Beautiful Bill Act
  • H.R. 879
    Medicare Patient Access and Practice Stabilization Act of 2025
  • S. 1640
    Medicare Patient Access and Practice Stabilization Act of 2025
  • H.R. 3164
    Ensuring Community Access to Pharmacist Services Act
  • S. 2426
    Equitable Community Access to Pharmacist Services Act
  • H.R. 6160
    Strengthening Medicare for Patients and Providers Act
  • H.R. 8163
    Provider Reimbursement Stability Act of 2026
  • H.R. 7520
    Efficiency Adjustment Delay Act
  • H.R. 8622
    Medicare Physician Data-driven Performance Payment System Act of 2026
  • H.R. 9693
    Patients First Act of 2026
  • H.R. 4331
    Access to Claims Data Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem